165 related articles for article (PubMed ID: 22135073)
1. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
Prabhakaran S; McNulty M; O'Neill K; Ouyang B
Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
[TBL] [Abstract][Full Text] [Related]
2. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.
Rajamani K; Millis S; Watson S; Mada F; Salowich-Palm L; Hinton S; Chaturvedi S
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):49-54. PubMed ID: 21852156
[TBL] [Abstract][Full Text] [Related]
4. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
7. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
8. United States trends in thrombolysis for older adults with acute ischemic stroke.
George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
[TBL] [Abstract][Full Text] [Related]
9. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
[TBL] [Abstract][Full Text] [Related]
10. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
11. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
[TBL] [Abstract][Full Text] [Related]
12. Impact of Stroke Center Certification on Thrombolysis Time Metrics in Telestroke Setting.
Almallouhi E; Ajinkya S; Rahwan M; Holmstedt CA; Al Kasab S
Telemed J E Health; 2021 Feb; 27(2):167-171. PubMed ID: 32397843
[No Abstract] [Full Text] [Related]
13. Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.
Man S; Zhao X; Uchino K; Hussain MS; Smith EE; Bhatt DL; Xian Y; Schwamm LH; Shah S; Khan Y; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004512. PubMed ID: 29794035
[TBL] [Abstract][Full Text] [Related]
14. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
16. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.
Mullen MT; Kasner SE; Kallan MJ; Kleindorfer DO; Albright KC; Carr BG
J Am Heart Assoc; 2013 Mar; 2(2):e000071. PubMed ID: 23537806
[TBL] [Abstract][Full Text] [Related]
17. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
19. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
20. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
